Biologics MiMedx Announces Executive to Lead its International Operations and Provides Update on Company’s International Progress byJosh SandbergJune 7, 2018
Hospitals AmnioFix® Injectable Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the FDA for the Treatment of Osteoarthritis of the Knee byJosh SandbergMarch 9, 2018
Biologics Recon MiMedx Announces Publication Of Latest Scientific Study Demonstrating The Ability Of Its Allografts To Regulate Diabetic Stem Cells byJosh SandbergAugust 27, 2015
Financial MiMedx Reports Record First Quarter 2015 Revenue of $40.8 Million byJosh SandbergApril 14, 2015